ATE329586T1 - Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon- induzierter nebenwirkungen - Google Patents
Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon- induzierter nebenwirkungenInfo
- Publication number
- ATE329586T1 ATE329586T1 AT01917436T AT01917436T ATE329586T1 AT E329586 T1 ATE329586 T1 AT E329586T1 AT 01917436 T AT01917436 T AT 01917436T AT 01917436 T AT01917436 T AT 01917436T AT E329586 T1 ATE329586 T1 AT E329586T1
- Authority
- AT
- Austria
- Prior art keywords
- adverse effects
- administration
- hormone
- side effects
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL135335A IL135335A (en) | 2000-03-29 | 2000-03-29 | Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE329586T1 true ATE329586T1 (de) | 2006-07-15 |
Family
ID=11073993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01917436T ATE329586T1 (de) | 2000-03-29 | 2001-03-28 | Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon- induzierter nebenwirkungen |
Country Status (16)
Country | Link |
---|---|
US (4) | US20010027216A1 (de) |
EP (1) | EP1267851B1 (de) |
JP (1) | JP5020455B2 (de) |
KR (1) | KR100818973B1 (de) |
CN (1) | CN1434707A (de) |
AT (1) | ATE329586T1 (de) |
AU (2) | AU4451101A (de) |
BR (1) | BR0107535A (de) |
CA (1) | CA2404097A1 (de) |
DE (1) | DE60120659T2 (de) |
ES (1) | ES2262635T3 (de) |
IL (1) | IL135335A (de) |
NO (1) | NO20024586L (de) |
RU (1) | RU2002125508A (de) |
SE (1) | SE0202857D0 (de) |
WO (1) | WO2001078701A2 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146449A0 (en) * | 2001-11-12 | 2002-07-25 | Lycored Natural Prod Ind Ltd | Method and pharmaceutical preparations for reducing the activity of cells |
TR201907898T4 (tr) * | 2003-01-31 | 2019-06-21 | Dsm Ip Assets Bv | Karotenoidler içeren yeni bileşimler. |
US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
US8521284B2 (en) | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
KR100739531B1 (ko) | 2004-05-07 | 2007-07-13 | 주식회사 이오텍 | 리코펜과 피토에스트로겐을 포함하는 혼합 조성물 |
US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
JP2006069910A (ja) * | 2004-08-31 | 2006-03-16 | Yoshiichi Sugimoto | 抗癌剤耐性克服剤 |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US7457664B2 (en) | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7805185B2 (en) | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
US7392086B2 (en) | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
US20080004665A1 (en) * | 2006-06-29 | 2008-01-03 | Mccabe Aaron R | Determination of cardiac pacing parameters based on non-localized sensing |
US8209013B2 (en) | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
JP5276119B2 (ja) | 2008-02-14 | 2013-08-28 | カーディアック ペースメイカーズ, インコーポレイテッド | 横隔刺激検出のための方法および装置 |
WO2010042364A2 (en) | 2008-10-06 | 2010-04-15 | Cardiac Pacemakers, Inc. | Dynamic cardiac resynchronization therapy by tracking intrinsic conduction |
JP6285866B2 (ja) | 2011-11-23 | 2018-02-28 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然複合ホルモン補充製剤および療法 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US9669006B2 (en) | 2015-07-28 | 2017-06-06 | U.S. Nutraceuticals, LLC | Composition and method to treat and alleviate symptoms of hot flashes in a female subject |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
EP3435977A4 (de) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | Pharmazeutische steroidhormonzusammensetzung |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN114300088B (zh) * | 2021-12-15 | 2023-06-16 | 苏州大学附属第二医院 | 用于指导围绝经期激素替代疗法的体温监控装置及系统 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3833350A (en) * | 1972-12-14 | 1974-09-03 | Amchem Prod | Method of inducing carotenoid accumulation in plant tissue |
US5422119A (en) * | 1987-09-24 | 1995-06-06 | Jencap Research Ltd. | Transdermal hormone replacement therapy |
US6132790A (en) | 1991-09-06 | 2000-10-17 | Betatene Limited | Carotenoid composition |
PT656786E (pt) * | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo |
IL103920A (en) | 1992-11-30 | 2000-07-26 | Makhteshim Chem Works Ltd | Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof |
AU6635994A (en) * | 1993-04-16 | 1994-11-08 | Tufts University School Of Medicine | Method for treatment of menopausal and premenstrual symptoms |
US6218436B1 (en) | 1993-06-28 | 2001-04-17 | The Howard Foundation | Pharmaceutically active carotenoids |
US5424331A (en) * | 1994-06-10 | 1995-06-13 | Bio-Virus Research Incorporated | Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis |
US5475006A (en) | 1994-08-10 | 1995-12-12 | National Research Council Of Canada | Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-differentiation inducers, anti-proliferative agents, and anti-tumor agents |
US5516528A (en) | 1995-01-13 | 1996-05-14 | Wake Forest University | Dietary phytoestrogen in estrogen replacement therapy |
US5643623A (en) | 1995-06-07 | 1997-07-01 | Mars Incorporated | Health food product and its uses |
US5807586A (en) * | 1996-07-30 | 1998-09-15 | Energetics, Inc. | Method of dietary supplementation |
US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
US6013665A (en) * | 1997-12-16 | 2000-01-11 | Abbott Laboratories | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
IL129442A0 (en) | 1999-04-14 | 2000-02-29 | Lycored Natural Prod Ind Ltd | Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood |
WO2001026668A1 (en) | 1999-10-14 | 2001-04-19 | Unilever N.V. | Compositions with anti-prostate cancer activity |
-
2000
- 2000-03-29 IL IL135335A patent/IL135335A/en not_active IP Right Cessation
-
2001
- 2001-03-05 US US09/799,140 patent/US20010027216A1/en not_active Abandoned
- 2001-03-05 US US09/799,251 patent/US7144586B2/en not_active Expired - Lifetime
- 2001-03-28 ES ES01917436T patent/ES2262635T3/es not_active Expired - Lifetime
- 2001-03-28 RU RU2002125508/14A patent/RU2002125508A/ru unknown
- 2001-03-28 CA CA002404097A patent/CA2404097A1/en not_active Abandoned
- 2001-03-28 AU AU4451101A patent/AU4451101A/xx active Pending
- 2001-03-28 CN CN01810131A patent/CN1434707A/zh active Pending
- 2001-03-28 US US10/240,090 patent/US8669293B2/en not_active Expired - Fee Related
- 2001-03-28 EP EP01917436A patent/EP1267851B1/de not_active Expired - Lifetime
- 2001-03-28 WO PCT/IL2001/000291 patent/WO2001078701A2/en active IP Right Grant
- 2001-03-28 AT AT01917436T patent/ATE329586T1/de not_active IP Right Cessation
- 2001-03-28 AU AU2001244511A patent/AU2001244511B2/en not_active Ceased
- 2001-03-28 BR BR0107535-7A patent/BR0107535A/pt not_active Application Discontinuation
- 2001-03-28 KR KR1020027012651A patent/KR100818973B1/ko not_active IP Right Cessation
- 2001-03-28 JP JP2001576002A patent/JP5020455B2/ja not_active Expired - Fee Related
- 2001-03-28 DE DE60120659T patent/DE60120659T2/de not_active Expired - Lifetime
-
2002
- 2002-09-25 NO NO20024586A patent/NO20024586L/no unknown
- 2002-09-27 SE SE0202857A patent/SE0202857D0/xx unknown
-
2004
- 2004-04-16 US US10/825,434 patent/US20040198674A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001078701A2 (en) | 2001-10-25 |
KR20020093858A (ko) | 2002-12-16 |
CA2404097A1 (en) | 2001-10-25 |
JP2003530428A (ja) | 2003-10-14 |
US7144586B2 (en) | 2006-12-05 |
US20040198674A1 (en) | 2004-10-07 |
US20010027216A1 (en) | 2001-10-04 |
DE60120659D1 (de) | 2006-07-27 |
IL135335A (en) | 2013-12-31 |
RU2002125508A (ru) | 2004-03-20 |
US20030148946A1 (en) | 2003-08-07 |
EP1267851B1 (de) | 2006-06-14 |
IL135335A0 (en) | 2001-05-20 |
NO20024586L (no) | 2002-11-25 |
US20030004146A1 (en) | 2003-01-02 |
DE60120659T2 (de) | 2007-06-06 |
CN1434707A (zh) | 2003-08-06 |
KR100818973B1 (ko) | 2008-04-04 |
AU4451101A (en) | 2001-10-30 |
SE0202857D0 (sv) | 2002-09-27 |
WO2001078701A3 (en) | 2002-07-25 |
NO20024586D0 (no) | 2002-09-25 |
ES2262635T3 (es) | 2006-12-01 |
EP1267851A2 (de) | 2003-01-02 |
JP5020455B2 (ja) | 2012-09-05 |
AU2001244511B2 (en) | 2006-04-27 |
BR0107535A (pt) | 2005-05-03 |
US8669293B2 (en) | 2014-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE329586T1 (de) | Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon- induzierter nebenwirkungen | |
HK1100480A1 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
BR0106681A (pt) | Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos | |
DE602004027936D1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
HK1097449A1 (en) | Methods for in vivo delivery of biologics and compositions useful therefor | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
DE69533112D1 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
ATE324039T1 (de) | Verwendung von spinosad oder einer zusammensetzung enthaltend spinosad | |
CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
ATE292453T1 (de) | Antivirale arznei | |
BR0207443A (pt) | Método e forma de dosagem para o tratamento de tumores pela administração de tegafur, uracila, ácido folìnico, paclitaxel e carboplatina | |
HK1085927A1 (en) | The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes | |
BRPI0414386A (pt) | composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição | |
HUP0203197A2 (hu) | Docetaxel alkalmazása hepatocelluláris karcinómák kezelésére | |
MXPA03001455A (es) | Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa. | |
MXPA05006081A (es) | Nuevos compuestos moduladores de los receptores de tipo receptor activado proliferador de peroxisoma del subtipo (ppar gamma) y su uso en composiciones cosmeticas o farmaceuticas. | |
TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
AR040287A1 (es) | Plataforma para formulaciones transdermicas (pft) | |
TR200200987T2 (tr) | Kanser tedavisine yönelik,ornatılmış pirroller | |
GB0018322D0 (en) | Pharmaceutical compositions | |
MD1780G2 (ro) | Metodă de tratament al pacienţilor cu ciroze hepatice | |
LT2001072A (lt) | Maisto papildas | |
BR0312283A (pt) | Combinação compreendendo um agente de alquilação e um agente redutor da atividade de vegf | |
DE50304524D1 (de) | Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole | |
UA41089A (uk) | Спосіб профілактики йодного дефіциту у дітей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |